Compare Eli Lilly And Co (LLY) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs ArcelorMittal SA — how do they compare? Eli Lilly And Co trades at $1,211.28 (market cap $1.08T), while ArcelorMittal SA trades at $74.2 (market cap $55.88B). The key difference: Eli Lilly And Co is far larger — about 19.3× ArcelorMittal SA's market cap, and ArcelorMittal SA pays the higher dividend (0.81%). Which is the better fit depends on your goals.
| LLY | MT | |
|---|---|---|
Market Cap | $1.08T | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $1.24K | $75.35 |
52-Week Low | $639.43 | $32.44 |
Enterprise Value | $1.13T | $65.45B |
Dividend Yield | 0.57% | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
